Uploaded June 2026 | Updated November 2026, 3 days ago
As health workers in the Democratic Republic of Congo (DRC) continue to battle an ongoing Ebola outbreak, scientists around the world are racing to develop a vaccine against the strain of the virus that’s causing it.
Two approved vaccines exist for Ebola (theconversation.com/topics/ebola-6354) , but they target the Zaire strain of the virus, not the Bundibugyo strain causing the 2026 outbreak, which has so far killed 61 people with 359 confirmed cases (cdc.gov/ebola/situation-summary/index.html) in the DRC and neighbouring Uganda.
In this episode, we speak to two scientists at the Oxford Vaccine Group at the University of Oxford, Teresa Lambe (theconversation.com/profiles/teresa-lambe-2701065) and Rebecca Makinson (theconversation.com/profiles/rebecca-makinson-2701063) , who are developing a vaccine candidate for Bundibugyo virus. On June 1, they were among three research groups to receive fast-track funding from the Coalition for Epidemic Preparedness Innovations (cepi.net/cepi-fast-tracks-three-bundibugyo-ebolavirus-vaccine-candidates) , alongside Moderna and IAVI.
This episode was written and produced by Gemma Ware, Katie Flood and Mend Mariwany. Mixing by Eleanor Brezzi and theme music by Neeta Sarl. Read the f (theconversation.com/a-glimpse-into-a-surreal-abyss-how-covid-ravaged-a-remote-city-in-the-amazonian-jungle-podcast-251941) ull credits for this episode (theconversation.com/the-scientists-racing-to-make-a-new-ebola-vaccine-to-combat-the-ongoing-epidemic-284483) and sign up here for a free daily newsletter (theconversation.com/uk/newsletters/the-daily-2) from The Conversation.
If you like the show, please consider donating to The Conversation (tcnv.link/2S1cahf) , an independent, not-for-profit news organisation.
As health workers in the Democratic Republic of Congo (DRC) continue to battle an ongoing Ebola outbreak, scientists around the world are racing to develop a vaccine against the strain of the virus that’s causing it.
Two approved vaccines exist for Ebola (theconversation.com/topics/ebola-6354) , but they target the Zaire strain of the virus, not the Bundibugyo strain causing the 2026 outbreak, which has so far killed 61 people with 359 confirmed cases (cdc.gov/ebola/situation-summary/index.html) in the DRC and neighbouring Uganda.
In this episode, we speak to two scientists at the Oxford Vaccine Group at the University of Oxford, Teresa Lambe (theconversation.com/profiles/teresa-lambe-2701065) and Rebecca Makinson (theconversation.com/profiles/rebecca-makinson-2701063) , who are developing a vaccine candidate for Bundibugyo virus. On June 1, they were among three research groups to receive fast-track funding from the Coalition for Epidemic Preparedness Innovations (cepi.net/cepi-fast-tracks-three-bundibugyo-ebolavirus-vaccine-candidates) , alongside Moderna and IAVI.
This episode was written and produced by Gemma Ware, Katie Flood and Mend Mariwany. Mixing by Eleanor Brezzi and theme music by Neeta Sarl. Read the f (theconversation.com/a-glimpse-into-a-surreal-abyss-how-covid-ravaged-a-remote-city-in-the-amazonian-jungle-podcast-251941) ull credits for this episode (theconversation.com/the-scientists-racing-to-make-a-new-ebola-vaccine-to-combat-the-ongoing-epidemic-284483) and sign up here for a free daily newsletter (theconversation.com/uk/newsletters/the-daily-2) from The Conversation.
If you like the show, please consider donating to The Conversation (tcnv.link/2S1cahf) , an independent, not-for-profit news organisation.










